Hypertrophic obstructive cardiomyopathy: Alternative therapeutic options

被引：20

作者：

Lakkis, N ^{[1
]}

Kleiman, N ^{[1
]}

Killip, D ^{[1
]}

Spencer, WH ^{[1
]}

机构：

[1] BAYLOR COLL MED,HOUSTON,TX 77030

来源：

关键词：

hypertrophic; obstructive; cardiomyopathy; alcohol; septal; reduction;

D O I：

10.1002/clc.4960200503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：417 / 418

页数：2

共 22 条

[1] CLELAND WP, 1963, J CARDIOVASC SURG, V4, P489
[2] COOLEY DA, 1976, J CARDIOVASC SURG, V17, P380
[3] COOPER MM, 1978, AM THORAC SURG, V44, P370
[4] IMPACT OF DUAL-CHAMBER PERMANENT PACING IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY WITH SYMPTOMS REFRACTORY TO VERAPAMIL AND BETA-ADRENERGIC BLOCKER THERAPY
FANANAPAZIR, L
CANNON, RO
TRIPODI, D
PANZA, JA
[J]. CIRCULATION, 1992, 85 (06) : 2149 - 2161
[5] LONG-TERM RESULTS OF DUAL-CHAMBER (DDD) PACING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - EVIDENCE FOR PROGRESSIVE SYMPTOMATIC AND HEMODYNAMIC IMPROVEMENT AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY
FANANAPAZIR, L
EPSTEIN, ND
CURIEL, RV
PANZA, JA
TRIPODI, D
MCAREAVEY, D
[J]. CIRCULATION, 1994, 90 (06) : 2731 - 2742
[6] HUBNER PJB, 1973, BRIT HEART J, V35, P1116
[7] EFFECTS OF DUAL-CHAMBER PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
JEANRENAUD, X
GOY, JJ
KAPPENBERGER, L
[J]. LANCET, 1992, 339 (8805) : 1318 - 1323
[8] Knight Charles J., 1996, Journal of the American College of Cardiology, V27, p256A
[9] KOBER G, 1987, Z KARDIOL, V76, P113
[10] KRAJCER Z, 1989, CIRCULATION, V80, P157